Matt Teague and Jessica Taylor, lawyers from our firm, assisted in this trial. Read more
In the state court trial, Mr. Couch sued AbbVie, claiming that his AndroGel use caused a severe heart attack at the end of 2013. Read more
The testosterone trial was still in progress when this issue went to the printer. Read more
There are more than 7,000 claims pending against the manufacturers of testosterone treatments. Read more
The Low-T lawsuits were consolidated for the purpose of general pretrial discovery. Read more
Dr. Gerstman is an expert for the Plaintiffs’ Steering Committee (PSC). Read more
Five lawsuits were filed recently against Abbott Laboratories Inc. and AbbVie Inc. It was alleged in each case that the companies downplayed the stroke and heart attack risks associated with... Read more
The Food and Drug Administration (FDA) is investigating possible increased risks of stroke, heart attack and death in men using testosterone replacement therapies. This move follows recent s... Read more
Bayer has agreed to a $74 million settlement in a case where Plaintiffs alleged the drug maker violated antitrust laws by participating in pay-for-delay activities surrounding its drug Cipro... Read more
AndroGel, a prescription topical testosterone gel manufactured by Abbott Laboratories, is used to treat adult males who have low testosterone and other conditions associated with testosteron... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.